3,4-Methylenedioxy-N-propylamphetamine
(Redirected from
Methylenedioxypropylamphetamine
)This article relies largely or entirely on a single source. (July 2019) |
Names | |
---|---|
Preferred IUPAC name
N-[1-(2H-1,3-Benzodioxol-5-yl)propan-2-yl]propan-1-amine | |
Identifiers | |
3D model (
JSmol ) |
|
ChemSpider | |
ECHA InfoCard
|
100.217.125 |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
Properties | |
C13H19NO2 | |
Molar mass | 221.300 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
3,4-Methylenedioxy-N-propylamphetamine (MDPR, "Phantom") is a lesser-known
MDPH
.
Shulgin reported that 160 mg of MDPR strongly enhanced the effects of a small (60 μg) dose of
LSD,[1] and that similar enhancement of hallucinogenic effect was noted when mixing MDPR with other drugs such as psilocybin, mescaline, 2C-B, and 2C-T-7
. The reason for this synergistic action of MDPR has not been elucidated. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDPR other than what is written in PiHKAL.